Benefits and Risks of Adjuvant Treatment with Zoledronic Acid in Stage Ii/Iii Breast Cancer. 10 Years Follow-Up of the Azure Randomized Clinical Trial (Big 01/04)

AuthID
P-00P-RDT
23
Author(s)
Coleman, RE
·
Collinson, M
·
Gregory, W
·
Marshall, H
·
Bell, R
·
Dodwell, D
·
Keane, M
·
Gil, M
·
Barrett Lee, P
·
Ritchie, D
·
[+3]·
O'Reilly, S
·
Bertelli, G
·
Joffe, J
·
Brown, JE
·
Wilson, C
·
Tercero, JC
·
Jean Mairet, J
·
Gomis, R
·
Cameron, D
Document Type
Article
Year published
2018
Published
in JOURNAL OF BONE ONCOLOGY, ISSN: 2212-1374
Volume: 13, Pages: 123-135 (13)
Indexing
Publication Identifiers
SCOPUS: 2-s2.0-85054721998
Wos: WOS:000450344400011
Source Identifiers
ISSN: 2212-1374
Export Publication Metadata
Marked List
Info
At this moment we don't have any links to full text documens.
Name Order Name   Name Order Name   Name Order Name
1 Coleman, RE;   2 Collinson, M;   3 Gregory, W;
4 Marshall, H;   5 Bell, R;   6 Dodwell, D;
7 Keane, M;   8 Gil, M;   9 Barrett Lee, P;
10 Ritchie, D;   11 Bowman, A;   12 Liversedge, V;
13 De Boer, RH;   14 Passos Coelho, JL;   15 O'Reilly, S;
16 Bertelli, G;   17 Joffe, J;   18 Brown, JE;
19 Wilson, C;   20 Tercero, JC;   21 Jean Mairet, J;
22 Gomis, R;   23 Cameron, D;